◆ 会议时间：2024年4月4-6日
◆ 会议地点：法国 巴黎（Paris, France）

◆ 会议简介：

2024年第20届欧洲皮肤肿瘤学协会(EADO)大会将于2024年4月4-6日在法国巴黎举行。

欧洲皮肤肿瘤学协会(EADO)是一个独立的非营利组织，致力于促进、协调和改进皮肤癌领域的临床和实验室研究活动，包括一级和二级预防、早期发现、临床诊断、临床与实验研究。EADO由来自欧洲和国际的皮肤科医师、肿瘤学家和临床医生以及对皮肤肿瘤学领域宣感兴趣的基础研究科学家组成；EADO通过制定和传播有关皮肤癌诊断和治疗的质量标准和指南来提供领导；为皮肤癌领域的临床、治疗和实验研究提供指导、协调和组织；支持并组织会议，以展示新的研究成果、交流信息和为其成员提供教育；对各国皮肤癌组织的项目提供协调与支持。

EADO每年组织一届学术大会，EADO大会是一个独特的机会，与会者可以参加由全球公认的黑色素瘤和皮肤癌领域的专家提供的讲座。会议议程涵盖黑色素瘤和皮肤癌的各个方面——从流行病学、诊断和预防到晚期肿瘤治疗试验结果等等，会议将确保与会者在皮肤肿瘤学领域获得卓越的教育和社交体验，预计有约1000名皮肤肿瘤学家、外科医生、放射治疗师、解剖病理学家、研究人员和业界专业人士将出席本次EADO年会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

EADO 2024 - 20th Congress of the European Association of Dermato-Oncology (EADO)
Date: April 4-6, 2024
Venue: Versailles Palais des Congrès, Paris, France

摘要征文投稿：

Abstract submission deadline: February 15, 2024 (6:00pm CET)

Abstracts may be submitted online via the congress website. Abstracts submitted by e-mail will not be accepted. 

Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered. 

The title should be as brief as possible but long enough to clearly indicate the nature of the study. Abbreviations must not be used in the title. The title should not be written entirely in capital letters (e.g. NOT LIKE THIS). 

Please indicate the topic from the abstract topics list and your preferred type of presentation (oral or poster). The Committee will endeavor to schedule abstracts according to authors’ preferences but reserves the right to decide on the final form of presentation. 

Encore abstracts will be accepted unless they have been published in scientific journals. 

Please structure the abstract as follows:

• Introduction & Objectives: Describe the background and the purpose of the study
• Materials & Methods: Describe the material and methods used to design the study
• Results: Describe your results in a logical sequence
• Conclusions: Emphasise new and important aspects of the study and conclusions that are drawn from them

The text shall not exceed 350 words including spaces (excluding title, authors bibliography and key words). The submission program will automatically calculate the number of characters in your abstract and will not allow submissions that exceed the maximum number of characters. 

It is acceptable to include up to two tables, graphics, or images (jpg, jpeg, png, gif format, maximum size 2 MB in total) as part of the abstract. 

All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. Abstracts will not be edited by the Congress Secretariat prior to publication, therefore please check the grammar and spelling carefully. 

Please use generic names. The use of commercial drug names, brands and registered trademarks are strictly prohibited. Drugs should be referred to by the active substance or pharmacological designation. 

No mention of pharmaceutical company names should be included in the abstract.

ABSTRACT TOPICS

• Actinic keratoses
• Basal cell carcinoma
• Cutaneous sarcoma
• Cutaneous T- and B-cell lymphoma
• Melanoma – Epidemiology and diagnostics
• Melanoma – Experimental and translational studies
• Melanoma – Immune checkpoint inhibitor (ICI) therapy
• Melanoma – Surgery
• Melanoma – Systemic therapy other than ICI therapy
• Merkel cell carcinoma
• Rare tumors
• Squamous cell carcinoma

Dear Colleagues,

We have the great pleasure to invite you to join us for the 20th EADO Congress taking place as an on-site meeting with additional virtual access from April 4–6, 2024 in Paris, France.

The European Association of Dermato-Oncology Congress is the largest conference in dermato-oncology worldwide, there are no competing meetings in this field. Over 1,400 participants from Europe and around the world are expected to attend.

The meeting provides updated scientific and clinical achievements in a wide spectrum of skin tumors including melanoma, keratinocyte carcinomas and rare malignant neoplasms. The world’s leading experts have been invited as speakers and will offer you the opportunity to gain comprehensive insight into all areas of dermato-oncology.

Paris is one of the world’s leading centers for art, fashion, gastronomy and culture and one of the most beautiful cities worldwide to explore. Close to the heart of Paris, the congress center Versailles Palais des Congrès offers renovated top-of-the-range meeting facilities and a less urban and more tree-lined environment. The venue is well accessible by the Metro station “Versailles Château Rive Gauche” and offers all the prerequisites for an unforgettable congress experience.

Looking forward to welcoming you in Paris in April 2024!

Prof. Dr. Céleste Lebbé

Paris, France
Congress President

Prof. Dr. Claus Garbe

Tuebingen, Germany
Congress President

注册费：

* The resident / student registration rate will be granted only after receipt of proof. The written proof of status (e.g. letter signed by the head of department confirming the status of the applicant / copy of student ID card) can be uploaded online during the registration process.
All above fees are inclusive VAT.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。